NCT03716076View on ClinicalTrials.gov

Carbetocin on Myocardial Repolarization Dynamics in Obstetrics Study

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

June 15, 2019

Study Completion Date

April 24, 2020

Conditions
Cardiac Arrythmias
Interventions
DRUG

Carbetocin

50 mcg or 100 mcg bolus of carbetocin

Trial Locations (1)

V6H 3N1

BC Women's Hospital, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT03716076 - Carbetocin on Myocardial Repolarization Dynamics in Obstetrics Study | Biotech Hunter | Biotech Hunter